Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Non-SMC condensin I complex subunit H enhances proliferation, migration, and invasion of hepatocellular carcinoma.

Sun C, Huang S, Wang H, Xie R, Zhang L, Zhou Q, He X, Ju W.

Mol Carcinog. 2019 Sep 15. doi: 10.1002/mc.23114. [Epub ahead of print]

PMID:
31523845
2.

Overexpression of NCAPH is upregulated and predicts a poor prognosis in prostate cancer.

Cui F, Hu J, Xu Z, Tan J, Tang H.

Oncol Lett. 2019 Jun;17(6):5768-5776. doi: 10.3892/ol.2019.10260. Epub 2019 Apr 17.

3.

NCAPH plays important roles in human colon cancer.

Yin L, Jiang LP, Shen QS, Xiong QX, Zhuo X, Zhang LL, Yu HJ, Guo X, Luo Y, Dong J, Kong QP, Yang CP, Chen YB.

Cell Death Dis. 2017 Mar 16;8(3):e2680. doi: 10.1038/cddis.2017.88.

4.

Exportin-T promotes tumor proliferation and invasion in hepatocellular carcinoma.

Lin J, Hou Y, Huang S, Wang Z, Sun C, Wang Z, He X, Tam NL, Wu C, Wu L.

Mol Carcinog. 2019 Feb;58(2):293-304. doi: 10.1002/mc.22928. Epub 2018 Nov 14.

5.

Activation of PI3K/AKT is involved in TINAG-mediated promotion of proliferation, invasion and migration of hepatocellular carcinoma.

Zhang MH, Niu H, Li Z, Huo RT, Wang JM, Liu J.

Cancer Biomark. 2018;23(1):33-43. doi: 10.3233/CBM-181277.

PMID:
29991125
6.

Oncogene Delta/Notch-Like EGF-Related Receptor Promotes Cell Proliferation, Invasion, and Migration in Hepatocellular Carcinoma and Predicts a Poor Prognosis.

Liang Y, Luo H, Zhang H, Dong Y, Bao Y.

Cancer Biother Radiopharm. 2018 Nov;33(9):380-386. doi: 10.1089/cbr.2018.2460. Epub 2018 Sep 20.

PMID:
30235011
7.

MCM6 promotes metastasis of hepatocellular carcinoma via MEK/ERK pathway and serves as a novel serum biomarker for early recurrence.

Liu M, Hu Q, Tu M, Wang X, Yang Z, Yang G, Luo R.

J Exp Clin Cancer Res. 2018 Jan 22;37(1):10. doi: 10.1186/s13046-017-0669-z.

8.
9.

ANGPTL2 promotes tumor metastasis in hepatocellular carcinoma.

Gao L, Ge C, Fang T, Zhao F, Chen T, Yao M, Li J, Li H.

J Gastroenterol Hepatol. 2015 Feb;30(2):396-404. doi: 10.1111/jgh.12702.

PMID:
25090954
10.

lncRNA MIAT promotes proliferation and invasion of HCC cells via sponging miR-214.

Huang X, Gao Y, Qin J, Lu S.

Am J Physiol Gastrointest Liver Physiol. 2018 May 1;314(5):G559-G565. doi: 10.1152/ajpgi.00242.2017. Epub 2017 Nov 2.

11.

The mu-opioid receptor is a molecular marker for poor prognosis in hepatocellular carcinoma and represents a potential therapeutic target.

Chen DT, Pan JH, Chen YH, Xing W, Yan Y, Yuan YF, Zeng WA.

Br J Anaesth. 2019 Jun;122(6):e157-e167. doi: 10.1016/j.bja.2018.09.030. Epub 2018 Dec 12.

PMID:
30915986
12.

Bromodomain-containing protein 7 (BRD7) as a potential tumor suppressor in hepatocellular carcinoma.

Chen CL, Wang Y, Pan QZ, Tang Y, Wang QJ, Pan K, Huang LX, He J, Zhao JJ, Jiang SS, Zhang XF, Zhang HX, Zhou ZQ, Weng de S, Xia JC.

Oncotarget. 2016 Mar 29;7(13):16248-61. doi: 10.18632/oncotarget.7637.

13.

miR-584-5p regulates hepatocellular carcinoma cell migration and invasion through targeting KCNE2.

Wei H, Wang J, Xu Z, Lu Y, Wu X, Zhuo C, Tan C, Tang Q, Pu J.

Mol Genet Genomic Med. 2019 Jun;7(6):e702. doi: 10.1002/mgg3.702. Epub 2019 May 1.

14.

Protein kinase CK2α catalytic subunit is overexpressed and serves as an unfavorable prognostic marker in primary hepatocellular carcinoma.

Zhang HX, Jiang SS, Zhang XF, Zhou ZQ, Pan QZ, Chen CL, Zhao JJ, Tang Y, Xia JC, Weng DS.

Oncotarget. 2015 Oct 27;6(33):34800-17. doi: 10.18632/oncotarget.5470.

15.

Anti-IL-20 monoclonal antibody suppresses hepatocellular carcinoma progression.

Ding WZ, Han GY, Jin HH, Zhan CF, Ji Y, Huang XL.

Oncol Lett. 2018 Nov;16(5):6156-6162. doi: 10.3892/ol.2018.9402. Epub 2018 Sep 5.

16.

Regulator of Calcineurin 1 Gene Isoform 4, Down-regulated in Hepatocellular Carcinoma, Prevents Proliferation, Migration, and Invasive Activity of Cancer Cells and Metastasis of Orthotopic Tumors by Inhibiting Nuclear Translocation of NFAT1.

Jin H, Wang C, Jin G, Ruan H, Gu D, Wei L, Wang H, Wang N, Arunachalam E, Zhang Y, Deng X, Yang C, Xiong Y, Feng H, Yao M, Fang J, Gu J, Cong W, Qin W.

Gastroenterology. 2017 Sep;153(3):799-811.e33. doi: 10.1053/j.gastro.2017.05.045. Epub 2017 Jun 2.

PMID:
28583823
17.

Fibulin-5 inhibits hepatocellular carcinoma cell migration and invasion by down-regulating matrix metalloproteinase-7 expression.

Tu K, Dou C, Zheng X, Li C, Yang W, Yao Y, Liu Q.

BMC Cancer. 2014 Dec 12;14:938. doi: 10.1186/1471-2407-14-938.

18.

Elevated FOXC2 Expression Promotes Invasion of HCC Cell Lines and is Associated with Poor Prognosis in Hepatocellular Carcinoma.

Yang F, Lv L, Zhang K, Cai Q, Liu J, Jiang Y.

Cell Physiol Biochem. 2017;44(1):99-109. doi: 10.1159/000484586. Epub 2017 Nov 6.

19.

Long noncoding RNA MINCR regulates cellular proliferation, migration, and invasion in hepatocellular carcinoma.

Cao J, Zhang D, Zeng L, Liu F.

Biomed Pharmacother. 2018 Jun;102:102-106. doi: 10.1016/j.biopha.2018.03.041. Epub 2018 Mar 22.

PMID:
29550632
20.

ODC1 promotes proliferation and mobility via the AKT/GSK3β/β-catenin pathway and modulation of acidotic microenvironment in human hepatocellular carcinoma.

Ye Z, Zeng Z, Shen Y, Yang Q, Chen D, Chen Z, Shen S.

Onco Targets Ther. 2019 May 27;12:4081-4092. doi: 10.2147/OTT.S198341. eCollection 2019.

Supplemental Content

Support Center